Viscoelastics

Comparative Reference Guide

Amvisc® Amvisc® Plus ClearVisc™ OcuCoat® StableVisc™ TotalVisc™

Includes ClearVisc™ & StableVisc™

Viscoelastic Cohesion Continuum

H I G H C O H E S I O N • M O D E R A T E C O H E S I O N • L O W C O H E S I O N

efficient removal StableVisc™ Amvisc ® Amvisc ® Plus Clearvisc™ OcuCoat ® lasting chamber retention

PRODUCT STABLEVISC® AMVISC® AMVISC® PLUS CLEARVISC™ OCUCOAT®

Moderate viscocity and Specifically designed with a molecular

Sterile solution of highly purified, medium cohesiveness facilitate weight and viscosity for endothelial
molecular weight sodium hyaluronate capsulorhexis and IOL cell protection2
Easy to use and No refrigeration³
implantation¹
Description remove¹ Optical
Proprietary formulation of sodium Ensures excellent tissue visualization
clarity¹ Highly lubricious³
hyaluronate and sorbitol to inhibit free Retained during Phaco¹ by minimizing the capture of bubbles
radicals6 and other material during the
Optical Clarity¹ procedure6

1.0 mL
Size 1.0 mL 0.8 mL 0.8 mL 1.0 mL
6x 1.0 mL

CC050S
Order # SVISC10 59081L 60081L DVISC10
CC065S

Order Number: TVISC20

Size: includes one 1.0 mL of StableVisc™ and one 1.0 mL of ClearVisc™

Description:
• Free radical protection - with two dual action formulations, ClearVisc™ and StableVisc™ provide free radical protection by creating
a strong physical barrier and eradicating free radicals chemically
• Total Protection – no other dual pack OVD system in the U.S. provides this unique complete solution, utilizing the protection of sorbitol
in both ClearVisc, dispersive and StableVisc™, cohesive
• Largest Fill Volume - TotalVisc™ leads the U.S. dual pack OVD market in fill volume of device with 1 mL of ClearVisc™ and 1 mL
of StableVisc™

CONFIDENTIAL: FOR INTERNAL USE ONLY.

NOT TO BE DISTRIBUTED OR USED IN PROMOTIONAL DETAILING.
Bausch + Lomb Customer Service: 800-338-2020 | bauschsurgical.com
Comparative Reference Guide
viscoelastics
VISCOSITY, CP MOLECULAR WEIGHT OSMOLALITY CANNULA
PRODUCT & COMPANY SIZE COMPOSITION COHESION
(AT 1S-1 SHEAR RATE, 25° C) (DALTONS) (MOSM / KG) SIZE

StableVisc™7,8 1.0% HA
1 mL 50,000 2.1 million Cohesive 340 27G
Bausch + Lomb 4% Sorbitol

Amvisc®1
0.8 mL 40,000 >1.0 million 1.2% HA Cohesive 320 27G
Bausch + Lomb

Amvisc® Plus1
0.8 mL 55,700 >80,000 1.6% HA Medium/Cohesive 340 27G
Bausch + Lomb

ClearVisc™2,7,8 2.5% HA
1.0 mL 40,000 <1.0 million Dispersive 330 25G
Bausch + Lomb 4% Sorbitol

OcuCoat®3 1.0 mL
4,000 >80,000 2.0% HPMC Dispersive 285 25G
Bausch + Lomb 2.0 mL

TotalVisc™
Includes one 1 mL of StableVisc and one 1 mL of ClearVisc
Bausch + Lomb

Viscoat®4 0.35 mL 3.0% HA Medium/

40,000 600,000 325 27G
Alcon 0.5 mL 4.0% CS Dispersive

0.4 mL
ProVisc®4
0.55 mL 39,000 2.4 million 1.0% HA Cohesive 310 27G
Alcon
0.85 mL

DuoVisc®4 Small includes 0.35 mL syringe of Viscoat and 0.4 mL syringe of ProVisc
Alcon Large includes 0.5 mL syringe of Viscoat and 0.55 mL syringe of ProVisc

DisCoVisc®4 1.65% HA
1.0 mL 75,000 1.65 million Dispersive 298 27G
Alcon 4.0% CS

Healon®PRO5 0.55 mL
150,000 3.2 million 1.0% HA Cohesive 302 27G
Johnson & Johnson 0.85 mL

HealonEndoCoat®5
0.85 mL 50,000 800,000 3% HA Dispersive 320 25G
Johnson & Johnson

Healon Duet PRO

Dual Pack5 Includes one 0.55 mL of Healon Pro OVD and one 0.85 mL of Healon EndoCoat OVD
Johnson & Johnson

Healon GV®PRO5
0.85 mL 2.0 million 3.2 million 1.8% HA Cohesive 302 27G
Johnson & Johnson

Healon5®PRO5
0.6 mL 4.0 million 3.2 million 2.3% HA Viscoadaptive 320 25G
Johnson & Johnson

Note: Information for viscoelastics not manufactured by Bausch + Lomb is obtained from each manufacturer’s product literature as noted below.

1. Amvisc ® and Amvisc ® Plus Directions for Use.

2. ClearVisc™ Directions for Use.
3. OcuCoat ® Directions for Use.
4. MyAlcon Professionals ©. Https://www.myalcon.com/professional/cataract-surgery/disposables/ovds/ (Accessed 2-21-23).
5. Johnson & Johnson Healon Family of OVDs Brochure. Https://www.jnjvisionpro.com/sites/us/files/public/surgical/OVD/jnj-cat-662_healon_
specification_sheet_updates_a4_v3final_020921.pdf (Accessed 2-21-23).
6. Erb W., Ayyagari M., Lau G., New Ophthalmic Viscosurgical Device (OVD) with Enhanced Hydroxyl Radical Scavenging Activity. May 2021, Virtual ARVO.
7. Packer M, Shultz M, Loden J, et al. Safety and effectiveness comparison of a new cohesive ophthalmic viscosurgical device. J Cataract Refract Surg. 2023.
8. Packer M, Berdahl JP, Goldberg DF, Hosten L, Lau G. Safety and effectiveness of a new ophthalmic viscosurgical device: randomized, controlled study. J
Cataract Refract Surg. 2022 Sep.

Product trademarks are owned by their respective manufacturers. No endorsement by manufacturers other than Bausch + Lomb is
expressed or implied. © 2023 Bausch + Lomb. SRG.0005.USA.23